Pirfenidone Modified-Release Tablets(Taizhou Overseas Pharma)

吡非尼酮双释片（越洋医药）

Report date: 2025/07/31 17:24:28
First In Class

Base Information

Drug NamePirfenidone Modified-Release Tablets(Taizhou Overseas Pharma)
Drug Alias Namepirfenidona哌非尼酮pirfenidonum吡啡尼酮甲苯吡啶酮
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta inhibitorsCytokines inhibitorsCollagen inhibitors
TargetsTransforming growth factor betaCytokinesCollagen
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG